What condition does Alfuzosin treat primarily?

Alfuzosin is primarily used to treat Benign Prostatic Hyperplasia (BPH), which is a common condition in older men characterized by an enlarged prostate gland that can cause urinary symptoms. The mechanism of action for Alfuzosin is that it is an alpha-1 adrenergic blocker, which helps to relax the muscles in the prostate and bladder neck. This relaxation improves urine flow and decreases the symptoms associated with BPH, such as difficulty starting urination, a weak stream, and the need to urinate frequently or urgently.

In contrast, the other conditions listed—hypertension, heart failure, and angina—require different types of medications and treatment strategies. Hypertension is typically managed with various antihypertensive agents, heart failure may require medications like diuretics or ACE inhibitors, and angina is usually treated with drugs that improve coronary blood flow, such as nitrates or beta-blockers. Therefore, the focus of Alfuzosin’s efficacy makes it specifically suited for the management of BPH.